Divestiture • Chemicals

Akzo Nobel Exits Akzo Nobel - North American Coatings Business

On December 14, 2014, invested in chemicals company Akzo Nobel - North American Coatings Business from Akzo Nobel for 1.1B USD

Investment Context
  • This is transaction in the Chemicals sector.
  • This is largest (disclosed) transaction.
  • This is transaction in the United States.

Explore All 1513 Divestiture Chemicals Deals - Search the Database Free


Investment Summary

Date December 14, 2014
Target Akzo Nobel - North American Coatings Business
Sector Chemicals
Sellers(s) Akzo Nobel
Deal Type Divestiture
Deal Value 1.1B USD

Target Company

Akzo Nobel - North American Coatings Business

United States
Akzo Nobel's North American is an architectural coatings business.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Seller Profile 1

SELLER

Akzo Nobel

Amsterdam, Netherlands

Category Company
Founded 1646
Sector Chemicals
Employees33,700
Revenue 10.7B EUR (2024)
DESCRIPTION

Akzo Nobel is a producer of decorative paints, performance coatings and specialty chemicals. Akzo Nobel was founded in 1646 and is based in Amsterdam, Netherlands.


Deal Context for Seller #
Overall 14 of 17
Sector: Chemicals 8 of 10
Type: Divestiture 1 of 1
Country: United States 2 of 3
Year: 2014 3 of 3
Size (of disclosed) 5 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-08 Akzo Nobel - Paper Chemical Business

Netherlands

AkzoNobel's paper chemicals business includes products for retention and sizing, as well as other paper chemicals, including wet strength and coating products.

Sell €153M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-02 Integrated Botanical Technologies

Ossining, New York, United States

Integrated Botanical Technologies, LLC - Zeta Fraction process and technology selectively isolates efficacious components from living plants and marine sources to produce a wide range of biofunctional ingredients. Targeted cellular fractions are gently separated based on unique patented technology, preserving the inherent value of the plant cell juice. Conventional plant extraction technology isolates botanical extracts from dried plants and uses external solvents that limit shelf life stability and reproducibility, among other limitations.

Sell -

Explore Related M&A Activity